Empirical Finance’s Bio-Techne TECH Stock Holding History

Empirical Finance’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$316K	Buy	4,478 +189	+4%	+$10.2K	0.01%	477
2026 Q1	$224K	Sell	4,289 -9	-0.2%	-$540	0.01%	473
2025 Q4	$253K	Sell	4,298 -195	-4%	-$11.8K	0.01%	466
2025 Q3	$250K	Buy	4,493 +54	+1%	+$2.89K	0.01%	493
2025 Q2	$228K	Buy	4,439 +40	+0.9%	+$2.01K	0.01%	495
2025 Q1	$258K	Buy	4,399 +314	+8%	+$21.3K	0.02%	478
2024 Q4	$294K	Buy	4,085 +5	+0.1%	+$367	0.02%	464
2024 Q3	$326K	Buy	4,080 +160	+4%	+$12K	0.02%	471
2024 Q2	$281K	Sell	3,920 -37	-0.9%	-$2.72K	0.02%	474
2024 Q1	$279K	Buy	3,957 +195	+5%	+$14K	0.02%	496
2023 Q4	$290K	Buy	3,762 +91	+2%	+$5.99K	0.02%	486
2023 Q3	$250K	Buy	3,671 +605	+20%	+$47.8K	0.02%	498
2023 Q2	$250K	Buy	+3,066	New	+$246K	0.02%	488

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Empirical Finance's TECH Position: Q2 2026 in Review

Empirical Finance increased its Bio-Techne (TECH) stake by 4.4% in Q2 2026, buying an estimated $10.2K and bringing the position to 4,478 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #477.

Empirical Finance first reported a position in TECH in Q2 2023 and has held it in 13 quarters since. The position peaked at $326K in Q3 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Empirical Finance held 4,478 shares of Bio-Techne worth $316K as of Q2 2026.
Empirical Finance bought 189 Bio-Techne shares in Q2 2026, an estimated $10.2K.
Bio-Techne made up 0.01% of Empirical Finance's portfolio in Q2 2026, its #477 holding.
Empirical Finance first reported a position in Bio-Techne in Q2 2023 and has held it in 13 quarters since.
Empirical Finance's Bio-Techne position peaked at $326K in Q3 2024.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Empirical Finance's 13F filing for Q2 2026, filed 14 Aug 2026.